Human iPS Cell and Organoid Technologies in Diseases, Drug Development, Toxicity, and Tissue Damage
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Methods".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 253
Special Issue Editors
Interests: pluripotent stem cells; neurosensory systems; stem cell differentiation; neuroplasticity; neurogenesis; retinal organoids; gene therapy; organ-on-chip
Special Issues, Collections and Topics in MDPI journals
Interests: pluripotent stem cells; neurosensory systems; stem cell differentiation; neuroplasticity; neurogenesis; retinal organoids; gene therapy; organ-on-chip
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The discovery that differentiated pluripotent stem cells exhibit the ability to give rise to complex tissue-like structures, commonly called organoids, has drastically changed the field of in vitro-based cell and disease modeling. An outstanding position in the latest developments has been awarded to organ-on-chip technologies, which can closely and physiologically recreate the function of human tissues. These in vitro systems allow for research developments and provide a platform for drug development and toxicity screening or tissue damage. For this Special Issue, we invite authors to submit full studies and reviews in the field of human iPS and organoid technologies.
Prof. Dr. Stefan Liebau
Dr. Kevin Achberger
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human iPS
- organoids
- organ-on-chip
